Research article · 17 Apr 2025
Mini reviewPublished 29 Nov 2022
Role of Fibroblast Growth Factor (FGF) in Suppressing Tumor in Patients with Colorectal Cancer
University of East Anglia, Norwich Research Park, Norwich, United Kingdom
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In colorectal cancer, fibroblast growth factor 14 (FGF14) was selectively methylated (CRC). In this work, we sought to elucidate the biological action, molecular mechanism, and epigenetic control of FGF14 in CRC. By using PCR and Western blot, the expression of FGF14 in CRC cell lines, normal human colon epithelial cell lines, CRC tissues, and matched neighbouring normal tissues was found. FGF14 blocked the PI3K/AKT/mTOR pathway and caused mitochondrial death. In conclusion, FGF14 is a new tumour suppressor that activates the PI3K/AKT/mTOR pathway to mediate cell death and restrict cell growth.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in World Journal of Pharmacology and Toxicology.
Editorial · 28 Mar 2025
Role of Reactive Oxygen Species in Experimental Models of Hepatorenal Toxicity
Editorial · 28 Mar 2025
Toxicological Evaluation of Novel Protein-Based Food Additives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalWorld Journal of Pharmacology and Toxicology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Charlie Javice”